Company profile: Precise Bio
1.1 - Company Overview
Company description
- Provider of regenerative medicine solutions, including 4D bio-fabricated corneas for transplantation, a 4D bio-fabrication platform that integrates tissue engineering, biomaterials, and cell technologies to create functional tissues and organs, and a 3D cardiac tissue patch for post-myocardial infarction to restore cardiac muscle viability and functionality.
Products and services
- 4D Bio-Fabrication Platform: An integrated platform that combines tissue engineering, biomaterials, and cell technologies to bio-fabricate functional tissues and organs for applications across diverse healthcare fields
- 4D Bio-Fabricated Corneas: Engineered corneal tissues for transplantation, addressing the global shortage of donated corneas by fabricating functional grafts using 4D bio-fabrication
- 3D Cardiac Tissue Patch: A bio-fabricated, implantable patch for post-myocardial infarction, intended to restore cardiac muscle viability and functionality following damage
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Precise Bio
Attgeno
HQ: Sweden
Website
- Description: Provider of pharmaceutical treatments for acute life-threatening conditions, including Supernitro, an intravenous drug for acute pulmonary hypertension that delivers nitric oxide directly to the lungs to reduce pulmonary blood pressure with minimal systemic effects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Attgeno company profile →
InaVein
HQ: United States
Website
- Description: Provider of innovative products to treat the full spectrum of vein disorders. Founded in 2007, InaVein develops and commercializes technologies including the TRIVEX System, which uses direct visualization to completely remove varicose veins in a shorter period of time compared to conventional phlebectomy procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InaVein company profile →
Arterial Remodeling Technologies
HQ: France
Website
- Description: Provider of bioresorbable peripheral and coronary polymer stents that promote the natural remodeling of injured arteries after angioplasty.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arterial Remodeling Technologies company profile →
Medos Medizintechnik
HQ: Germany
Website
- Description: Provider of medical devices for cardiac surgery, extracorporeal membrane oxygenation, and ventricle assist devices, offering VAD cannulae, X-Flow, DELTASTREAM, HILITE, HILITE Reservoirs, and tubing sets (machine-sets, table-sets).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medos Medizintechnik company profile →
Cortex E&P
HQ: United States
Website
- Description: Provider of an integrated suite of technologies for assessing and treating atrial fibrillation (AFib) with precision, simplicity, and speed.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cortex E&P company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Precise Bio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Precise Bio
2.2 - Growth funds investing in similar companies to Precise Bio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Precise Bio
4.2 - Public trading comparable groups for Precise Bio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →